Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.07 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.07 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |